Catalyst Wire Dossier Catalyst Wire Dossier

TissueGene-C

TG-C · Kolon TissueGene, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for TissueGene-C, covering 2015-01-22 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee [Phase 3]

See pricing